Brief: New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
06/11/2025 13:45
Nov 6 (Reuters) - Guardant Health Inc GH.O: NEW STUDY VALIDATES GUARDANT REVEAL BLOOD TEST’S EFFECTIVENESS IN MONITORING CHEMOTHERAPY RESPONSE GUARDANT HEALTH: PATIENTS WHO EXPERIENCED OVER 98% REDUCTION IN TUMOR SIGNAL SAW MOST SIGNIFICANT BENEFITS GUARDANT HEALTH: RISE IN TUMOR SIGNAL IDENTIFIED DISEASE PROGRESSION UP TO 18 MONTHS EARLIER WITH MEDIAN LEAD TIME OF 2.3 MONTHS Source text: ID:nBw95n5f3a Further company coverage: GH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte